Anixa Biosciences Operating Expenses 2011-2026 | ANIX

Annual Operating Expenses Anixa Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	9.98 M	11.6 M	14.1 M	6.33 M	4.59 M	6.55 M	6.72 M	7.99 M	5.08 M	6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.1 M	4.59 M	7.88 M

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	58 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Brainsway Ltd. BWAY	29.2 M	$ 13.65	-0.44 %	$ 99.4 M	Israel
Aspira Women's Health AWH	37.1 M	-	-6.19 %	$ 10.5 M	USA
Bioventus BVS	217 M	$ 8.87	2.9 %	$ 591 M	USA
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Charles River Laboratories International CRL	607 M	$ 151.97	-2.34 %	$ 7.53 B	USA
Castle Biosciences CSTL	59.5 M	$ 25.83	1.06 %	$ 717 M	USA
CareDx, Inc CDNA	411 M	$ 17.32	1.82 %	$ 923 M	USA
DexCom DXCM	1.89 B	$ 66.34	3.27 %	$ 25.9 B	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Exact Sciences Corporation EXAS	2.47 B	$ 103.85	0.27 %	$ 19.6 B	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	181 M	$ 14.95	1.22 %	$ 452 M	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Biodesix BDSX	106 M	$ 17.29	-3.3 %	$ 2.24 B	USA
Guardant Health GH	226 M	$ 87.18	1.98 %	$ 10.9 B	USA
Danaher Corporation DHR	6.71 B	$ 191.39	2.17 %	$ 136 B	USA
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
ICON Public Limited Company ICLR	408 M	$ 97.61	-0.73 %	$ 8.05 B	Irlanda
IQVIA Holdings IQV	2.94 B	$ 164.89	0.1 %	$ 28.3 B	USA
Illumina ILMN	3.69 B	$ 119.28	0.29 %	$ 19 B	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 198.94	-0.38 %	$ 22.1 B	USA
QIAGEN N.V. QGEN	821 M	-	-	$ 10.6 B	Niderland
Agilent Technologies A	1.99 B	$ 111.83	0.28 %	$ 34 B	USA
BioNano Genomics BNGO	41.3 M	$ 1.11	-	$ 1.41 M	USA
DarioHealth Corp. DRIO	62.2 M	$ 8.42	-6.44 %	$ 239 M	Israel
Lantheus Holdings LNTH	123 M	$ 78.5	-1.25 %	$ 5.3 B	USA
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
Co-Diagnostics CODX	45.3 M	$ 4.4	101.83 %	$ 129 M	USA
Medpace Holdings MEDP	118 M	$ 453.64	0.72 %	$ 13.1 B	USA
Motus GI Holdings MOTS	18.6 M	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	1.01 B	$ 1 198.71	2.13 %	$ 24.7 B	Schweiz
Celcuity CELC	113 M	$ 114.9	0.6 %	$ 4.53 B	USA
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
Neogen Corporation NEOG	1.48 B	$ 9.11	0.22 %	$ 1.98 B	USA
National Research Corporation NRC	38.5 M	$ 17.4	5.33 %	$ 389 M	USA
NeoGenomics NEO	430 M	$ 8.24	4.57 %	$ 1.06 B	USA
Invitae Corporation NVTA	343 M	-	-	$ 21.2 M	USA
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	258 M	$ 197.68	5.23 %	$ 19.5 B	USA
OPKO Health OPK	217 M	$ 1.19	-	$ 826 M	USA
Pacific Biosciences of California PACB	600 M	$ 1.36	2.26 %	$ 408 M	USA